课题基金 / 基金详情

CONFERENCE ON TYPE 2 CYTOKINES

CONFERENCE ON TYPE 2 CYTOKINES
2 型细胞因子会议
批准号:
2743552
负责人:
FRED Douglass FINKELMAN
金额:
$0.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2000-01-31

项目摘要

项目成果

FRED Douglass FINKELMAN的其他基金

相似基金

相关文献

中文摘要
翻译
类似的炎症、免疫和生理事件具有特征 包括过敏和蠕虫感染。加深对角色的理解 在引发这些事件的过程中特定的细胞因子对 过敏和寄生虫学研究。双方共同面临的关键问题 研究领域包括了解T细胞细胞因子反应是如何 调节和如何在细胞因子、炎性细胞和 炎症介质限制蠕虫感染并产生过敏反应 症状。这次会议将促进研究人员之间的交流 在过敏、哮喘和寄生虫学中的观点认为, 而用来研究某一领域的技术通常会受益 另一种是学习。全体会议的议题包括监管 细胞因子、抗原和抗原提呈细胞对细胞因子的反应; 抗体、炎性细胞、炎性介质和 神经系统在过敏、哮喘和驱虫中的作用;细胞因子和 胃肠和肺生理的神经调节, 反应性和炎症。将举行联合全体会议 与同期召开的哮喘动物模型会议和 过敏和哮喘的免疫治疗。联合研讨会将涵盖 嗜酸性粒细胞、肥大细胞和嗜碱性粒细胞在变态反应、哮喘和 宿主防御、哮喘的动物模型和新的治疗方法。
英文摘要
Similar inflammatory, immunologic, and physiologic events characterize both allergy and worm infections. Increased understanding of the roles of specific cytokines in evoking these events has had a major impact on both allergy and parasitology research. Critical issues common to both research fields include understanding how T cell cytokine responses are regulated and how interactions among cytokines, inflammatory cells and inflammatory mediators limit worm infections and produce allergic symptoms. This conference will promote communication among researchers in allergy, asthma and parasitology with the view that ideas, reagents, and techniques that are used to study one field will often benefit studies in the other. Plenary session topics include regulation of cytokine responses by cytokines, antigens, and antigen presenting cells; roles of antibodies, inflammatory cells, inflammatory mediators, and the nervous system in allergy, asthma, and worm expulsion; and cytokine and neural regulation of gastrointestinal and pulmonary physiology, responsiveness and inflammation. Joint plenary sessions will be held with the concurrent asthma meeting on animal models of asthma and immunotherapy of allergy and asthma. Joint workshops will cover the roles of eosinophils, mast cells, and basophils in allergy, asthma, and host defense, animal models of asthma, and novel approaches to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10468082
  • 项目类别:
  • 资助金额:
    $56.61万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10213608
  • 项目类别:
  • 资助金额:
    $56.61万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10645062
  • 项目类别:
  • 资助金额:
    $54.12万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Wimpy antibody isotypes protect against antibody-mediated disease
  • 批准号:
    9287287
  • 项目类别:
  • 资助金额:
    $37.18万
  • 财政年份:
    2017
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
海外基金